Top Upgrades
- Analysts at Stifel Nicolaus upgraded Schlumberger Limited SLB from Hold to Buy. Schlumberger rose 1.8 percent to $35.68 in pre-market trading.
- JP Morgan upgraded Garmin Ltd. GRMN from Underweight to Neutral. Garmin shares fell 0.1 percent to close at $78.37 on Thursday.
- Analysts at Piper Jaffray upgraded Helmerich & Payne, Inc. HP from Neutral to Overweight. Helmerich & Payne shares rose 0.4 percent to close at $51.18 on Thursday.
- Goldman Sachs upgraded Exelon Corporation EXC from Neutral to Buy. Exelon shares rose 0.2 percent to $50.33 in pre-market trading.
- Citigroup upgraded WP Carey Incey WPC from Sell to Neutral. W.P. Carey shares rose 0.4 percent to $84.64 in pre-market trading.
- JP Morgan upgraded Matador Resources Co MTDR from Neutral to Overweight. Matador Resources shares rose 0.8 percent to $16.41 in pre-market trading.
- Vertical Research upgraded JetBlue Airways Corporation JBLU from Hold to Buy. JetBlue shares rose 0.3 percent to $17.98 in pre-market trading.
- Raymond James upgraded Helix Energy Solutions Group Inc HLX from Outperform to Strong Buy. Helix Energy shares closed at $6.98 on Thursday.
- KeyBanc upgraded Anaplan Inc PLAN from Sector Weight to Overweight. Anaplan shares rose 2.4 percent to $48.50 in pre-market trading.
- Wedbush upgraded Glu Mobile Inc. GLUU from Neutral to Outperform. Glu Mobile rose 2.1 percent to $7.20 in pre-market trading.
Top Downgrades
- Telsey Advisory Group downgraded Michaels Companies Inc MIK from Outperform to Market Perform. Michaels shares fell 1 percent to $8.10 in pre-market trading.
- JP Morgan downgraded QEP Resources Inc QEP from Neutral to Underweight. QEP Resources shares fell 2.8 percent to $6.49 in pre-market trading.
- JP Morgan downgraded Centennial Resource Development Inc CDEV from Overweight to Neutral. Centennial Resource Development shares fell 1.2 percent to close at $7.46 on Thursday.
- Argus Research downgraded Skyworks Solutions Inc SWKS from Buy to Hold. Skyworks shares fell 0.6 percent to $69.00 in pre-market trading.
- Guggenheim downgraded Mirati Therapeutics Inc MRTX from Buy to Neutral. Mirati Therapeutics shares fell 1.4 percent to $95.56 in pre-market trading.
- BMO Capital downgraded Camping World Holdings Inc CWH from Outperform to Market Perform. Camping World shares fell 2.6 percent to $11.78 in pre-market trading.
- Piper Jaffray downgraded Texas Capital Bancshares Inc TCBI from Overweight to Neutral. Texas Capital Bancshares fell 1.2 percent to $59.15 in pre-market trading.
- Jefferies downgraded Invesco Ltd. IVZ from Buy to Hold. Invesco shares fell 1.5 percent to $20.45 in pre-market trading.
- Stephens & Co. downgraded Mammoth Energy Services Inc TUSK from Overweight to Equal-Weight. Mammoth Energy shares rose 2.3 percent to $6.25 in pre-market trading.
- UBS downgraded American Tower Corp AMT from Buy to Neutral. American Tower shares fell 0.4 percent to $211.78 in pre-market trading.
Top Initiations
- Analysts at Goldman Sachs initiated coverage on Veeva Systems Inc VEEV with a Neutral rating. The price target for Veeva is set to $151. Veeva shares closed at $159.00 on Thursday.
- Analysts at Stifel initiated coverage on X4 Pharmaceuticals Inc XFOR with a Buy rating. The price target for X4 Pharmaceuticals is set to $27. X4 Pharmaceuticals shares closed at $13.95 on Thursday.
- Analysts at Nomura initiated coverage on Applied Materials, Inc. AMAT with a Neutral rating. The price target for Applied Materials is set to $40. Applied Materials closed at $41.38 on Thursday.
- Seaport Global initiated coverage on Select Interior Concepts Inc SIC with a Buy rating. The price target for Select Interior Concepts is set to $15. Select Interior Concepts shares closed at $10.04 on Thursday.
- Deutsche Bank initiated coverage on Waitr Holdings Inc WTRH with a Buy rating. Waitr shares closed at $5.68 on Thursday.
- Citigroup initiated coverage on Activision Blizzard, Inc. ATVI with a Neutral rating. The price target for Activision Blizzard is set to $47. Activision Blizzard closed at $44.08 on Thursday.
- Roth Capital initiated coverage on Fate Therapeutics Inc FATE with a Neutral rating. The price target for Fate Therapeutics is set to $20. Fate Therapeutics closed at $17.71 on Thursday.
- Stephens & Co. initiated coverage on Establishment Labs Holdings Inc ESTA with an Overweight rating. The price target for Establishment Labs is set to $37. Establishment Labs shares closed at $22.22 on Thursday.
- Analysts at Oppenheimer initiated coverage on Agile Therapeutics Inc AGRX with an Outperform rating. The price target for Agile Therapeutics is set to $5. Agile Therapeutics shares closed at $1.03 on Thursday.
- Goldman Sachs initiated coverage on New Relic Inc NEWR with a Sell rating. The price target for New Relic is set to $83. New Relic shares closed at $100.50 on Thursday.
Loading...
Loading...
AMATApplied Materials Inc
$155.244.22%
AMTAmerican Tower Corp
$223.60-0.19%
CWHCamping World Holdings Inc
$14.076.22%
ESTAEstablishment Labs Holdings Inc
$33.397.57%
EXCExelon Corp
$46.56-0.09%
FATEFate Therapeutics Inc
$1.337.26%
GRMNGarmin Ltd
$191.782.68%
HLXHelix Energy Solutions Group Inc
$6.584.94%
HPHelmerich & Payne Inc
$20.233.00%
IVZInvesco Ltd
$14.413.52%
JBLUJetBlue Airways Corp
$4.758.45%
MTDRMatador Resources Co
$40.600.27%
SLBSchlumberger Ltd
$34.773.05%
SWKSSkyworks Solutions Inc
$66.061.27%
TCBITexas Capital Bancshares Inc
$70.582.66%
TUSKMammoth Energy Services Inc
$2.600.78%
VEEVVeeva Systems Inc
$236.501.91%
WPCW.P. Carey Inc
$61.69-0.31%
XFORX4 Pharmaceuticals Inc
$3.852.67%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in